US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 40.170
  • +0.970+2.47%
Close Jan 2 16:00 ET
  • 40.170
  • 0.0000.00%
Post 16:34 ET
3.06BMarket Cap-14.30P/E (TTM)

Xenon Pharmaceuticals Key Stats

Xenon Pharmaceuticals Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
EPS
-0.81
-0.81
+<0.01
Beat Est.
-11.17%
-10.96%
+0.17%
Net Income
--
-62.79M
--
-29.57%
Strong Buy

Dec 31, 2024

Xenon Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 312.500K--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 312.500K--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Xenon Pharmaceuticals Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data